Welcome to SR Biomedical !

About Us

Company Profile

SR Biomedical has a distinguished founding team and elite external consultants, each a seasoned leader and expert in the biopharmaceutical and IP domains. Our expertise centers on forging robust, scalable, and top-tier IP management and business development solutions for the biopharmaceutical sector. As your 'in-house IP expert', we don't just offer advice - we elevate your enterprise value. Leveraging the prowess of AI technology, we combine innovative drug R&D insights with global patent protection acumen, crafting an agile and smart IP rights management system, shielding your novel drug R&D endeavors, seamlessly integrating your enterprise into the global IP ecosystem, and positioning you as a strong competitor in global innovation.

Ensure market exclusivity and maximise the commercial value of the product

Facilitating technology transfer (Licence) to maximise the commercial value of the technology

Increased valuation of the company and enhanced ability of the company to raise funds

Fueling the virtuous cycle of R&D, returns, and reinvestment

Service Content

Grow together with Chinese innovative pharmaceutical companies.

Integrating over 20 years of IP management experience in multinational pharmaceutical companies and IP&BD experience in Chinese Biotech, we provide one-stop services for new drug research and development companies.

Tailored services
Building an IP system
Leading business expansion

Team

Sunny Xuhong Wang

Founder
CEO

More than 30 years of experience in the pharmaceutical industry and over 20 years of experience in IP field. From the frontline of research and development, to the protection and management of IP rights for multinational pharmaceutical companies, and then to the business expansion of innovative drugs. Serving multiple Chinese biopharmaceutical companies, leading and participating in project initiation, IP strategy formulation, global patent strategy layout, business expansion and licensing, transfer, etc. As the patent operations officer of Sanofi, starting from a patent information analyst, becoming the global head of patent operations and entering the core management team of Sanofi's IP department. Responsible for the operation of over 60000 patents, including over 400 listed and under development products. The establishment of a global patent management system and a strategic management system for new drug research and development patents in Sanofi has greatly increased the efficiency of IP operations.


Master's degree in Biochemistry; 2021 Suzhou Intellectual Property Leading Talent; Chief Intellectual Property Officer of the Yangtze River Delta Trading Center; US Patent Agent.

Cathy Xiaoyan Zhong

Founding Partner
COO

With over 25 years in the drug R&D and biotechnology sectors, she brings profound expertise in areas from drug R&D to IP management and business growth. She once established and directed a dynamic 60-member international R&D registration team for a Fortune 500 firm. In 2018, returning to China, she assumed a senior role at a Chinese biopharmaceutical startup, overseeing its operations, strategy, and IP management. She was pivotal in shaping macromolecular and chemical drug R&D platforms, fostering IP strategy, and facilitating numerous business collaborations via leveraging IP. As the firm's IP leader, she achieved significant milestones, including dozens of priority and PCT applications, and patent authorizations in the US, Europe, Japan, and China, often collaborating with top-tier domestic and international law firms.


Bachelor of Medicine, Master of Pharmacology, Doctor of Genetics, and Postdoctoral in Molecular Biology. Leading talent of Suzhou Industrial Park in 2021; 2022 Suzhou Intellectual Property Special Talent.

Jian Wang

Founding Partner
IP Senior Consultant

Having over 12 years of experience in intellectual property industry. Former Grade IV patent examiner in the chemical and pharmaceutical sectors of the China National Intellectual Property Administration, senior search expert of the China National Intellectual Property Administration, and as reserved trainer/instructor. During this period, over 800 patents within organic  and pharmaceutical chemistry were reviewed, and over 40 were re-examined; More than 30 search reports on the stability, patentability, and FTO reports ; Undertake multiple enterprise commissioned patent conversion, patent warning, and patent strategic projects; Conduct training on enterprise intellectual property management, patent mining layout, and high-value patent cultivation. Served as the Chief Expert/Senior Advisor on Intellectual Property for multiple innovative pharmaceutical companies, specializing in intellectual property management for chemical and biopharmaceutical enterprises, with rich work experience in innovative drugs, generic drugs, and market commerce.


PhD in Chemistry; Chinese patent agent.

Shuangshuang Li

Founding Team Member
IP Consultant

Having 6 years of experience in biopharmaceutical patent examination and 2 years of experience in intellectual property management in biotech. Previously responsible for patent substantive examination in the fields of antibody drug conjugates, delivery carriers, and formulations. As a pharmaceutical companyIPR, he is responsible for IP management of small molecule, peptide, protein and other drug pipelines, helped the company obtain patent rights in multiple countries and regions such as China, America, Europe, and Japan,provided project research, patent search, patent layout, patent writing, trademark application and management for the company. Excellent New Examiner and Model Examiner of the Chinese Patent Office. Proficient in fields such as medicine, biochemistry, chemistry, etc. The advantages lie in search analysis, patent application, intellectual property training, trademark management, etc.


Master of Chemistry, Chinese Patent Agent.

Adviser

Client Feedback